Size	O
effect	O
of	O
Au	B:C0018026
/	O
Polyamidoamine	B:C1609342
contrast	B:C0009924
agent	I:C0009924
on	O
CT	B:C0040405
imaging	I:C0040405
of	O
reticuloendothelial	B:C0035287
system	I:C0035287
and	O
tumor	B:C0475358
tissue	I:C0475358
.	O

Polyamidoamine	B:C1609342
(	O
Polyamidoamine	B:C1609342
)	O
-	O
entrapped	O

Au	B:C0018026
nanoparticles	O
were	O
synthesized	O
with	O
distinct	O
sizes	O
to	O
figure	O
out	O
the	O
size	O
effect	O
of	O
Au	B:C0018026
-	O
based	O
contrast	B:C0009924
agent	I:C0009924
on	O
CT	B:C0040405
imaging	I:C0040405
of	O
passively	O
targeted	B:C0599894
tissues	B:C0475358
.	O

Au	B:C0018026
/	O
Polyamidoamine	B:C1609342
nanoparticles	O
were	O
first	O
synthesized	O
with	O
narrow	O
distribution	B:C0037775
of	O
particles	O
size	O
of	O
22.2	O
±	O
3.1	O
,	O
54.2	O
±	O
3.7	O
,	O
and	O
104.9	O
±	O
4.7	O
nm	O
in	O
diameters	O
.	O

Size	O
effect	O
leads	O
no	O
significant	O
difference	O
on	O
X	B:C1306645
-	I:C1306645
ray	I:C1306645
attenuation	O
when	O
Au	B:C0018026
/	O
Polyamidoamine	B:C1609342
was	O
≤	O
0.05	O
mol	O
/	O
L.	O

For	O
CT	B:C0040405
imaging	I:C0040405
of	O
a	O
tumor	B:C0475358
model	I:C0475358
,	O
small	O
Au	B:C0018026
/	O
Polyamidoamine	B:C1609342
were	O
more	O
easily	O
internalized	O
via	O
endocytosis	B:C0014139
in	O
the	O
liver	B:C0023884
,	O
leading	O
to	O
more	O
obviously	O
enhanced	B:C1512095
contrast	I:C1512095
.	O

Similarly	O
,	O
contrast	B:C0009924
agents	I:C0009924
with	O
small	O
sizes	O
were	O
more	O
effective	O
in	O
tumor	B:C0475358
imaging	B:C0011923
because	O
of	O
the	O
enhanced	B:C0007605
permeability	I:C0007605
and	O
retention	B:C1753315
effect	I:C1753315
.	O

Overall	O
,	O
the	O
particle	O
size	O
of	O
Au	B:C0018026
/	O
Polyamidoamine	B:C1609342
heavily	O
affected	O
the	O
efficiency	O
of	O
CT	O
enhancement	O
in	O
imaging	B:C0011923
RES	B:C0035287
and	O
tumors	B:C0475358
.	O

